The variation of faecal calprotectin after 3 months of anti-TNF therapy is a predictor of sustained clinical remission in patients with Crohn's disease

被引：0
|
作者：
Sollelis, E. [1 ,2 ,3 ]
Quinard, R. Minet [4 ]
Bouguen, G. [5 ]
Goutte, M. [1 ,2 ,3 ]
Goutorbe, F. [1 ,6 ]
Bouvier, D. [4 ]
Pereira, B. [7 ]
Bommelaer, G. [1 ,2 ,3 ]
Buisson, A. [1 ,2 ,3 ]
机构：
[1] Univ Hosp Estaing, Gastroenterol Dept, Clermont Ferrand, France
[2] Univ Auvergne, INSERM, UMR 1071, Clermont Ferrand, France
[3] USC INRA 2018, Microbes Intestine Inflammat & Susceptibil Host, Clermont Ferrand, France
[4] Univ Hosp G Montpied, Biochem Lab, Clermont Ferrand, France
[5] Univ Hosp, Rennes, France
[6] Hosp Bayonne, Gastroenterol Dept, Bayonne, France
[7] Univ Hosp, Biostat Unit, DRCI Clermont Ferrand, Clermont Ferrand, France
来源：
JOURNAL OF CROHNS & COLITIS | 2018年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P504
引用
收藏
页码：S360 / S360
页数：1
相关论文
共 50 条
  • [1] FECAL CALPROTECTIN AFTER 3 MONTHS OF ANTI-TNF THERAPY STRONGLY PREDICTS PROLONGED CLINICAL REMISSION IN PATIENTS WITH CROHN'S DISEASE
    Sollelis, Elisa
    Minet-Quinard, Regine
    Bouguen, Guillaume
    Goutte, Marion
    Goutorbe, Felix
    Bouvier, Damien
    Pereira, Bruno
    Bommelaer, Gilles
    Buisson, Anthony
    GASTROENTEROLOGY, 2018, 154 (06) : S825 - S826
  • [2] Faecal calprotectin can be used to monitor response to therapy in anti-TNF treated patients with Crohn's disease
    Saleem, R.
    Dubois, P.
    Chung-Faye, G.
    Bjarnason, I.
    Hayee, B.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S268 - S268
  • [3] Faecal calprotectin variation after induction therapy with infliximab to predict clinical, endoscopic and ultrasonographic remission in Crohn's disease patients
    Reves, J.
    Morao, B.
    Gomes, C. F.
    Nascimento, C.
    Abreu, N.
    Goncalves, T. C.
    Castro, F.
    Freitas, M.
    Moreira, M. J.
    Cotter, J.
    Pereira, F.
    Caldeira, A.
    Sousa, R.
    Coelho, R.
    Macedo, G.
    Macedo, C.
    Ferreira, M.
    Gloria, L.
    Torres, J.
    Palmela, C.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I378 - I378
  • [4] Faecal calprotectin variation after induction therapy with infliximab to predict clinical, endoscopic and ultrasonographic remission in Crohn's disease patients
    Reves, J.
    Morao, B.
    Gomes, C. F.
    Nascimento, C.
    Abreu, N.
    Goncalves, T. C.
    Castro, F.
    Freitas, M.
    Moreira, M. J.
    Cotter, J.
    Pereira, F.
    Caldeira, A.
    Sousa, R.
    Coelho, R.
    Macedo, G.
    Macedo, C.
    Ferreira, M.
    Gloria, L.
    Torres, J.
    Palmela, C.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I378 - I378
  • [5] FAECAL CALPROTECTIN IDENTIFIES NON RESPONDERS TO ANTI-TNF THERAPY WHEN MEASURED AFTER INDUCTION IN INFLAMMATORY CROHN'S DISEASE
    Pavlidis, P.
    Cavazza, A.
    Siddique, N.
    Stamoulos, P.
    Tumova, J.
    Medcalf, L.
    Chung-Faye, G.
    Dubois, P.
    Bjarnason, I.
    Hayee, B.
    GUT, 2015, 64 : A431 - A432
  • [6] Sustained clinical remission in patients with moderate to severe Crohn's disease with adalimumab, regardless of anti-TNF history or concomitant immunosuppressant therapy
    Hanauer, Stephen B.
    D'Haens, G. R.
    Colombel, J. F.
    Sandborn, W. J.
    Rutgeerts, P.
    Kent, J. D.
    Pollack, P. F.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S457 - S457
  • [7] Early change in faecal calprotectin predicts primary non-response to anti-TNF therapy in Crohn's disease
    Pavlidis, Polychronis
    Gulati, Shraddha
    Dubois, Patrick
    Chung-Faye, Guy
    Sherwood, Roy
    Bjarnason, Ingvar
    Hayee, Bu'Hussain
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2016, 51 (12) : 1447 - 1452
  • [8] Anti-TNF therapy and Crohn's disease
    Peyrin-Biroulet, L.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2008, 32 (05): : 478 - 481
  • [9] Anti-TNF Therapy in Crohn's Disease
    Adegbola, Samuel O.
    Sahnan, Kapil
    Warusavitarne, Janindra
    Hart, Ailsa
    Tozer, Philip
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (08)
  • [10] Another anti-TNF therapy for patients with Crohn's disease
    Cross, Raymond
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (03) : 425 - 427
12345